CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net (loss) income	$ (3,712)	$ 1,316
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Share-based compensation expense	644	559
Depreciation and amortization	758	747
Deferred income taxes	(2,008)	(104)
Foreign currency transaction losses	59	153
Changes in operating assets and liabilities:
Accounts receivable	1,429	(367)
Inventories	(446)	82
Prepaid income taxes	87	11
Other current and long term assets	150	(576)
Accounts payable	(685)	(853)
Accrued liabilities and other liabilities	(508)	(120)
Net cash (used in) provided by operating activities	(4,232)	848
Cash flows from investing activities:
Capital expenditures	(634)	(796)
Additions to capitalized software	0	(304)
Issuance of note receivable	(600)	(1,000)
Net cash used in investing activities	(1,234)	(2,100)
Cash flows from financing activities:
Revolving credit line borrowings	2,756	0
Revolving credit line payments	(2,756)	0
Long-term debt borrowings	2,173	0
Payment of common stock issuance costs	(71)	0
Payment of dividends on common stock	0	(2,011)
Proceeds from stock option exercises	353	0
Withholding taxes paid on stock issuances	(41)	(214)
Payment of bank financing costs	(213)	0
Net cash provided by (used in) financing activities	2,201	(2,225)
Effect of exchange rate changes on cash and cash equivalents	9	(7)
Decrease in cash and cash equivalents	(3,256)	(3,484)
Cash and cash equivalents, beginning of period	4,203	4,691
Cash and cash equivalents, end of period	947	1,207
Supplemental schedule of non-cash investing activities:
Capital expenditures included in accounts payable	$ 15	$ 91